S
01099
Sinopharm Group
20.320
-0.420-2.03%Closed16:08 04/17 HKT
OPEN/PREV CLOSE20.280/20.280
TODAY RANGE19.730-20.280
VOL6.30M
MARKET CAP61.88B
52 WEEK RANGE17.280-22.340
AVG VOL (3M)5.65M
% TURNOVER0.20%
TURNOVER125.15M
P/E (TTM)7.812
% RANGE2.71%
EPS(TTM)2.539
P/E(FORWARD)7.002
P/B0.666
BVPS29.785
DIVIDEND0.786
P/S0.097
BETA--
DIV YIELD3.96%
FREE FLOAT MKT CAP26.61B
SHARES OUTSTANDING3.12B
NEXT EARNINGS04/28-05/05
FREE FLOAT1.34B
LOT SIZE400
EX-DATE06/23/2026
News
Press Releases
Financial Reports
Profile
Reuters·1d ago
SINOPHARM GROUP Q1 REVENUE RMB 17,823 MILLION
Reuters·04/10 08:43
Sinopharm schedules board meeting to review unaudited first-quarter results
Simply Wall St·03/28 02:08
A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement
Reuters·03/22 22:16
Sinopharm Group proposes final dividend of RMB 0.69 per share
Simply Wall St·03/20 08:12
Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention
Reuters·03/17 22:14
Sinopharm Accord net profit rises 76.8% to RMB1.14 billion in 2025
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.